32 research outputs found
Optimizing outcomes for patients with severe haemophilia A
Full text linkPeer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73864/1/j.1365-2516.2007.01552.x.pd
Estudo da influência do torque de inserção na resistência ao arrancamento dos parafusos pediculares
Full text link
Antithrombin and fibrinogen levels as predictors for plasma L‐asparaginase activity in children with acute lymphoblastic leukemia
No full textAn unrelated cytogenetic karyotype and intra-lineage shift at relapse of an aggressive paediatric B-precursor ALL
No full textExperience with generic pegylated L-asparaginase in children with acute lymphoblastic leukemia and monitoring of serum asparaginase activity
No full textA Bayesian approach to the assessment of inhibitor risk in studies of factor VIII concentrates
No full textFDA Drug Approval Summary: Pegaspargase (Oncaspar®) for the First‐Line Treatment of Children with Acute Lymphoblastic Leukemia (ALL)
No full textSafety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China
No full textProphylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)
No full text
